Showing results (591-600 of 1,167) with videos related to
Sort By:
Pageof 117
Asian Pacific Journal of Cancer Prevention : APJCP|February 27, 2014
Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resectionXiao-Yan Cai, Jia-Xing Wang, Yong Yi, et al.Plos One|May 13, 2014
Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patientsXiao-Yong Huang, Chi Zhang, Jia-Bin Cai, et al.Biotechnology for Biofuels and Bioproducts|June 14, 2024
Synergistic and stepwise treatment of resveratrol and catechol in Haematococcus pluvialis for the overproduction of biomass and astaxanthinJia-Fan Qiu, Yu-Cheng Yang, Ruo-Yu Li, et al.Portal Hypertension & Cirrhosis|July 15, 2026
Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management ImplicationsJiayan Yan, Jiayi Wang, Jian Fan, et al.Journal of Cellular and Molecular Medicine|February 21, 2019
Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learningRui-Zhao Dong, Xuan Yang, Xin-Yu Zhang, et al.Plos One|February 6, 2014
Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinomaYi-Wei Li, Jia-Xing Wang, Xin Yin, et al.Journal of Experimental & Clinical Cancer Research : CR|April 23, 2013
Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinomaRui Liao, Han Wu, Yong Yi, et al.Journal of Cancer Research and Clinical Oncology|March 19, 2009
Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 casesXin-Da Zhou, Zhao-You Tang, Zeng-Chen Ma, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 14, 2014
Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implicationsChi Zhang, Li-Xin Liu, Zhao-Ru Dong, et al.Cell Death & Disease|July 26, 2020
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinomaFei Song, Bo Hu, Jian-Wen Cheng, et al.Pageof 117